oral glp 1 pfizer Danuglipron New oral GLP-1 drugs could

No changes were observed in the normoinsulinemic subjects (Fig

Signature bacteria, including Lactobacillus intestinalis and Bacteroides acidifaciens , were enriched, and these were associated with SCFAs, intestinal inflammation, and renal function ( The dysregulation of intestinal microorganisms and enzyme activity is implicated in the occurrence of diarrhea

Cc nghin cu cho thy thc phm giu cysteine nh bt Whey Protein c th lm tng lng glutathione, t gim stress oxy ha

The company is also launching a pen-device version but has not disclosed pricing

For patients with severe or persistent GI symptoms, temporary dose reduction or holding the GLP-1 medication (under clinician guidance) may be considered